2024-03-28T23:52:15Zhttp://digital.csic.es/dspace-oai/requestoai:digital.csic.es:10261/1217982016-04-14T10:43:42Zcom_10261_134com_10261_1col_10261_387
2015-09-08T11:23:23Z
urn:hdl:10261/121798
Concise review: Human pluripotent stem cells in the treatment of spinal cord injury
Lukovic, Dunja
Moreno-Manzano, Victoria
Stojkovic, Miodrag
Bhattacharya, Shom Shanker
Erceg, Slaven
Instituto de Salud Carlos III
Ministerio de Ciencia e Innovación (España)
Junta de Andalucía
Stem cell transplantation
Tissue regeneration
Induced pluripotent stem cells
Embryonic stem cells
Spinal cord injury
Spinal cord injury (SCI) results in neural loss and consequently motor and sensory impairment below the injury. There are currently no effective therapies for the treatment of traumatic SCI in humans. Different kinds of cells including embryonic, fetal, and adult stem cells have been transplanted into animal models of SCI resulting in sensorimotor benefits. Transplantation of human embryonic stem cell (hESC)- or induced pluripotent stem cell (hiPSC)-derived neural cells is nowadays a promising therapy for SCI. This review updates the recent progress in preclinical studies and discusses the advantages and flaws of various neural cell types derived from hESCs and hiPSCs. Before introducing the stem cell replacement strategies in clinical practice, this complex field needs to advance significantly in understanding the lesion itself, the animal model adequacy, and improve cell replacement source. This knowledge will contribute to the successful translation from animals to humans and lead to established guidelines for rigorous safety screening in order to be implemented in clinical practice. © AlphaMed Press.
2015-09-08T11:23:23Z
2015-09-08T11:23:23Z
2012-08-20
2015-09-08T11:23:23Z
artículo
Stem Cells 30(9): 1787-1792 (2012)
http://hdl.handle.net/10261/121798
10.1002/stem.1159
http://dx.doi.org/10.13039/501100004587
http://dx.doi.org/10.13039/501100004837
http://dx.doi.org/10.13039/501100011011
eng
http://dx.doi.org/10.1002/stem.1159
Sí
closedAccess
John Wiley & Sons